This NCI grant is for currently funded U01 research projects. Its primary purpose is to encourage revision applications that aim to accelerate progress or expand original research by integrating novel technical approaches or instruments. These technologies must have been developed with support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. The grant seeks to incentivize independent validation of these emerging tools, accelerating their adoption and suitability within relevant research communities. A key goal of this initiative, part of the NCI IMAT program, is to foster interdisciplinary collaboration. This ultimately enables the development of innovative methods and tools crucial for advancing cancer research and accelerating scientific discovery.
Opportunity ID: 351179
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-24-013 |
Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Nov 28, 2023 |
Original Closing Date for Applications: | Oct 01, 2024 |
Current Closing Date for Applications: | Oct 01, 2024 |
Archive Date: | Nov 06, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | $150,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Independent school districts County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Special district governments Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-013.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 351179 Full Announcement-RFA-CA-24-013 -> RFA-CA-24-013-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283924 | Mar 01, 2024 | Oct 01, 2024 | View |
Package 1
Mandatory forms
351179 RR_SF424_5_0-5.0.pdf
351179 PHS398_CoverPageSupplement_5_0-5.0.pdf
351179 RR_OtherProjectInfo_1_4-1.4.pdf
351179 PerformanceSite_4_0-4.0.pdf
351179 RR_KeyPersonExpanded_4_0-4.0.pdf
351179 PHS398_ResearchPlan_5_0-5.0.pdf
351179 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351179 RR_Budget_3_0-3.0.pdf
351179 RR_SubawardBudget30_3_0-3.0.pdf
351179 PHS398_ModularBudget_1_2-1.2.pdf
351179 PHS_AssignmentRequestForm_3_0-3.0.pdf